Proventa International will be gathering over 100 C-Level Directors from a mix of emerging to large Pharmaceutical, Biotechnology & Academic/Research Institutions to help solve their key strategic challenges in the area of Oncology.
The Oncology Roundtable Discussions Strategy Meeting are for qualified end-users. These include Senior Executives of Oncology/Immuno-Oncology (from medium to large Pharma, Biopharma and Biotech players) in global development positions spanning early development to phase IV, as well as thought leaders from Academia and regulatory authorities.
Register now and Book your seat. Limited slots only.